Business Description
Wanbangde Pharmaceutical Holding Group Co Ltd
NAICS : 212299
SIC : 3334
ISIN : CNE000001P94
Share Class Description:
SZSE:002082: Class ACompare
Compare
Traded in other countries / regions
002082.China IPO Date
2006-11-20Description
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 11.37 | |||||
Interest Coverage | 2.65 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.08 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -52 | |||||
3-Year EBITDA Growth Rate | -30.6 | |||||
3-Year EPS without NRI Growth Rate | -51.9 | |||||
3-Year FCF Growth Rate | 21.3 | |||||
3-Year Book Growth Rate | 0.5 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.54 | |||||
9-Day RSI | 47.73 | |||||
14-Day RSI | 44.86 | |||||
6-1 Month Momentum % | -29.33 | |||||
12-1 Month Momentum % | -36.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.34 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 106.46 | |||||
Days Sales Outstanding | 224.07 | |||||
Days Payable | 112.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.78 | |||||
Dividend Payout Ratio | 0.92 | |||||
3-Year Dividend Growth Rate | -7.2 | |||||
Forward Dividend Yield % | 1.85 | |||||
5-Year Yield-on-Cost % | 2.88 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -2.53 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.29 | |||||
Operating Margin % | 7.78 | |||||
Net Margin % | 3.2 | |||||
FCF Margin % | -1.25 | |||||
ROE % | 1.91 | |||||
ROA % | 1.16 | |||||
ROIC % | 2.44 | |||||
ROC (Joel Greenblatt) % | 3.57 | |||||
ROCE % | 2.97 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 52.68 | |||||
PE Ratio without NRI | 33.23 | |||||
Shiller PE Ratio | 11.93 | |||||
PS Ratio | 1.68 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 1.27 | |||||
Price-to-Operating-Cash-Flow | 19.64 | |||||
EV-to-EBIT | 39.01 | |||||
EV-to-EBITDA | 39.01 | |||||
EV-to-Revenue | 2.2 | |||||
EV-to-FCF | -175.34 | |||||
Price-to-Median-PS-Value | 4.55 | |||||
Price-to-Graham-Number | 1.37 | |||||
Price-to-Net-Current-Asset-Value | 13.5 | |||||
Earnings Yield (Greenblatt) % | 2.56 | |||||
FCF Yield % | -0.75 | |||||
Forward Rate of Return (Yacktman) % | -33.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wanbangde Pharmaceutical Holding Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,585.883 | ||
EPS (TTM) (Â¥) | 0.082 | ||
Beta | 1.5 | ||
Volatility % | 27.75 | ||
14-Day RSI | 44.86 | ||
14-Day ATR (Â¥) | 0.159795 | ||
20-Day SMA (Â¥) | 4.359 | ||
12-1 Month Momentum % | -36.02 | ||
52-Week Range (Â¥) | 3.7 - 7.65 | ||
Shares Outstanding (Mil) | 616.69 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Wanbangde Pharmaceutical Holding Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Wanbangde Pharmaceutical Holding Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Wanbangde Pharmaceutical Holding Group Co Ltd Frequently Asked Questions
What is Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082)'s stock price today?
The current price of SZSE:002082 is ¥4.32. The 52 week high of SZSE:002082 is ¥7.65 and 52 week low is ¥3.70.
When is next earnings date of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082)?
The next earnings date of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is .
Does Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) pay dividends? If so, how much?
The Dividend Yield %  of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is 2.78% (As of Today), Highest Dividend Payout Ratio of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) was 2.4. The lowest was 0.2. And the median was 0.65. The  Forward Dividend Yield % of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is 1.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |